We look at Monsanto Company (NYSE:MON) [Trend Analysis] a company in the Agricultural Chemicals industry getting a lot of attention at the moment, to assess if it provides value for investors considering buying or selling it. Currently Monsanto Company is trading at $97.31 after moving up 2.26% in the previous day of trading.
MON is trading with a trailing 12 month P/E multiple of 20.70 and an estimated forward P/E multiple of 15.32. The stock has an estimated 5 year annual growth of 10.35% and a PEG multiple of 2.00.
Rather than the usual Price to Earnings (P/E) multiple method, we use a slightly different method to assess if Monsanto Company is potentially a value buy for investors, the PEG ratio (P/E to growth). This PEG multiple takes into account the expected long term growth in earnings of the company rather than merely the growth for one earnings period ahead as forward P/E does.
That is to say, P/E simply doesn’t account for the long term prospects of MON. As a rule of thumb, a stock with a PEG of between 0 and 1 is usually considered to be underpriced, between 1 and 2 to be at fair value and over 2 to be overpriced. Based on the PEG ratio of MON being 2.00, we consider Monsanto Company to likely be priced at fair value.
This analysis means that value buyers who do not currently hold Monsanto Company (NYSE:MON) should probably look for better value alternatives and investors currently holding the stock should either continue to hold or sell and look for alternatives.
The mean analyst 12 month target price for Monsanto Company (NYSE:MON) is currently $106.89 or 9.84% above the current price. Additionally, the stock has been as high as $126.00 and as low as $81.22 in the last 52 weeks. Analysts are estimating that MON will report earnings per share of $2.99 next quarter.
The post Pricing Analysis: Monsanto Company (NYSE:MON) appeared first on Stock Markets Daily.